Bilastine - CAS 202189-78-4
Catalog number: 202189-78-4
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
Histamine Receptor
Description:
Bilastine is a novel, nonsedating H1-antihistamine developed for symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.
Publictions citing BOC Sciences Products
  • >> More
Purity:
0.99
Synonyms:
Bilastine, trade name Bilaxten
MSDS:
Inquire
1. Comparative inhibition by bilastine and cetirizine of histamine-induced wheal and flare responses in humans
Martin K. Church. Inflamm. Res. (2011) 60:1107–1112
Early clinical trials have also shown bilastine to be a potent and effective H1-antihistamine. In a study of 525 patients with chronic idiopathic urticaria, bilastine 20 mg once daily significantly (P<0.001 compared with pla- cebo) relieved the symptoms. Furthermore, the overall efficacy results demonstrated that bilastine was of similar efficacy to levocetirizine. In the nose, a double-blind cross-over study in which 75 allergic volunteers were challenged with grass pollen in the Vienna Challenge Chamber showed bilastine to be equally effective as cetirizine and fexofenadine but the results obtained suggest that it has a longer duration than fexofenadine, while in two 14-day trials in seasonal allergic rhinitis, bilastine was shown to be of similar efficacy to daily dosage with 10 mg cetirizine and 5 mg desloratadine.
2. Allergic Conjunctivitis and the Impact of Allergic Rhinitis
Leonard Bielory. Curr Allergy Asthma Rep (2010) 10:122–134
Antihistamines: Bilastine and Bepotastine Recent clinical data suggest an ocular and nasal allergy efficacy profile for bilastine, a new oral antihistamine, similar to that of established oral antihistamines, including desloratadine and cetirizine. In addition, another oral antihistamine agent, bepotastine, was shown to be effective and well-tolerated in patients with Japanese cedar allergen–induced symptoms in an exposure chamber and was recently approved in the United States in an ophthalmic formulation with a very similar profile to those of olopatadine and epinastine.
3. New Therapies for Allergic Rhinitis
Fulvio Braido & Francesca Sclifò & Matteo Ferrando & Giorgio Walter Canonica. Curr Allergy Asthma Rep (2014) 14:422
Bilastine, a new nonsedating H1 receptor inverse agonist, belongs to the piperidine class along with loratadine, desloratadine, and fexofenadine. In vitro studies have shown that bilastine has a high specific affinity for the H1 receptor but no or very low affinity for 30 other tested receptors. This affinity for the H1 receptor is three and six times higher than for cetirizine and fexofenadine, respectively. Bilastine behaves as an H1 mixed antagonist (competitive up to 33 nM; not competitive from 100 nM), as it is 5.5 times more powerful than cetirizine as a competitive antagonist and 10 times more powerful as a noncompetitive antagonist. The effectiveness of bilastine is comparable to that of desloratadine. Besides its H1 antagonism, bilastine has also demonstrated anti-inflammatory properties, including inhibiting the release of proinflammatory cytokines such as IL-4 and tumor necrosis factor-α. Furthermore, in vivo studies in rats demonstrated a significant reduction in histamine-stimulated endothelial permeability, microvascular extravasation, and inhibition of smooth muscular contraction and bronchospasm times that of cetirizine.
4. Integration of preclinical and clinical knowledge to predict intravenous PK in human: Bilastine case study
Valvanera Vozmediano • Ignacio Ortega • John C. Lukas • Ana Gonzalo • Monica Rodriguez • Maria Luisa Lucero. Eur J Drug Metab Pharmacokinet (2014) 39:33–41
First PK modeling was performed for the i.v. and p.o. data in animals alone. Two compartmental representations best described the kinetics of bilastine in animals. The results of Jauregizar et al. (2009) were applied for p.o. bilastine in man. The PK parameters for all species are listed in Table 3 (for p.o. in rat, dog and man and for i.v. in rat and dog). Table 3 also lists the protein binding fraction (fu) for bilastine in these three species.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Histamine Receptor Products


CAS 147-24-0 Diphenhydramine HCl

Diphenhydramine HCl
(CAS: 147-24-0)

Diphenhydramine HCl (Benadryl), a histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a ...

CAS 68-88-2 Hydroxyzine

Hydroxyzine
(CAS: 68-88-2)

Hydroxyzine is a histamine H1-receptor antagonist.

CAS 113-69-9 Benzquinamide Hydrochloride

Benzquinamide Hydrochloride
(CAS: 113-69-9)

Benzquinamide hydrochloride is an antiemetic compound with antihistaminic, anticholinergic and sedative properties. The mechanism of action is not quite sure an...

OUP16
(CAS: 1038917-11-1)

OUP16 is a potent and selective histamine H4 receptor(hH4R) agonist with 40-fold selectivity over the hH3R and superior to its (2S,5S)-configured optical antipo...

Bavisant dihydrochloride hydrate
(CAS: 1103522-80-0)

The dihydrochloride hydrate salt form of Bavisant which is an orally bioavaliable and selective H3 receptor antagonist that could probably useful in the treatme...

CAS 3964-81-6 Azatadine

Azatadine
(CAS: 3964-81-6)

Azatadine is a new antihistamine acts as histamine for histamine H1- receptor inhibitor ( IC50 = 6.5 nM and 10 nM, respectively).

CAS 720690-73-3 GSK 189254A

GSK 189254A
(CAS: 720690-73-3)

GSK-189,254 is a H3 histamine receptor inverse agonist. It has subnanomolar affinity for the H3 receptor with Ki of 0.2nM. It possesses stimulant and nootropic ...

CAS 83881-51-0 Cetirizine

Cetirizine
(CAS: 83881-51-0)

Cetirizine, a second-generation antihistamine, is a major metabolite of hydroxyzine. It is a racemic selective H1 receptor inverse agonist. It is used in cutane...

CAS 2508-72-7 Antazoline hydrochloride

Antazoline hydrochloride
(CAS: 2508-72-7)

Antazoline HCl is a first generation antihistamine, binding to the histamine H1 receptor and blocking the action of endogenous histamine.

CAS 1229-35-2 METHDILAZINE HYDROCHLORIDE (200 MG)

METHDILAZINE HYDROCHLORIDE (200 MG)
(CAS: 1229-35-2)

This active molecular is a first-generation antihistamine and belongs to phenothiazine class. Methdilazine Hydrochloride is a Histamine H1 receptor antagonist w...

CAS 100643-71-8 Desloratadine

Desloratadine
(CAS: 100643-71-8)

Desloratadine is a potent antagonist for human histamine H1 receptor with IC50 of 51 nM.

CAS 6153-33-9 Mebhydroline Napadisylate

Mebhydroline Napadisylate
(CAS: 6153-33-9)

Mebhydroline Napadisylate is an antihistamine used for symptomatic relief of allergic symptoms caused by histamine release, including nasal allergies and allerg...

CAS 13461-01-3 aceprometazine

aceprometazine
(CAS: 13461-01-3)

Aceprometazine is a Histamine H1 receptor antagonist as an approved drug. It can be used in combination with meprobamate for the treatment of sleep disorders su...

CAS 83799-24-0 Fexofenadine

Fexofenadine
(CAS: 83799-24-0)

Fexofenadine is Histamine H1 receptor antagonist. It can be used for the treatment of allergy symptoms, such as hay fever, nasal congestion, and urticaria.

CAS 3614-69-5 Dimetindene maleate

Dimetindene maleate
(CAS: 3614-69-5)

Dimethindene is a histamine H1 antagonist of high potency used orally and locally as an antipruritic.

CAS 190786-44-8 Bepotastine Besilate

Bepotastine Besilate
(CAS: 190786-44-8)

Bepotastine stimulates P-gp-mediated ATP hydrolysis with Km, Vmax, and Vmax/Km values of 1.25 mM, 108 nmol/min/mg protein, and 0.087 mL/min/mg protein, respecti...

CAS 80012-43-7 Epinastine

Epinastine
(CAS: 80012-43-7)

Epinastine is a second-generation antihistamine and mast cell stabilizer that is used in eye drops to treat allergic conjunctivitis. It is highly selective for ...

CAS 5638-76-6 Betahistine

Betahistine
(CAS: 5638-76-6)

Betahistine is a H1 receptor agonist, which serves as a vasodilator. It is used in Meniere disease and in vascular headaches but may exacerbate bronchial asthma...

CAS 929622-08-2 Bavisant

Bavisant
(CAS: 929622-08-2)

Bavisant is a highly selective, orally active antagonist of the human H3 receptor. It is a novel mechanism of action, involving wakefulness and cognition. It ha...

CAS 24219-97-4 Mianserin

Mianserin
(CAS: 24219-97-4)

Mianserin is a tetracyclic second generation antidepressant. It has the same efficacy as the tricyclics, but has no anticholinergic and cardiovascular side-effe...

Chemical Structure

CAS 202189-78-4 Bilastine

Quick Inquiry

Verification code

Featured Items